Ketorolac Good Anaesthesia for Laparoscopic Bariatric Surgery
Study Into Effects of Analgesia and Anesthetic for Gastric Bypass
| Bariatric Surgery information Ketorolac Good Anaesthesia for Laparoscopic Bariatric Surgery |
Study Into Effects of Analgesia and Anesthetic for Gastric Bypass |
Guide to Weight Loss Surgery - Research Into Gastric Reduction Surgery |
|
Ketorolac Provides Good Anaesthesia for Laparoscopic Bariatric Surgery According to new research data, Ketorolac reduces postoperative complications and improves outcomes when used in laparoscopic surgery for morbid obesity. Dr. Ramasamy Govindarajan presented the results of the bariatric study at the 13th World Congress of Anaesthesiologists. Laparoscopic Gastric Bypass Patients His team enrolled 50 patients with morbid obesity scheduled to undergo laparoscopic gastric bypass surgery. Half of the group was randomised to receive IV ketorolac perioperatively, instead of narcotics, continued for 24 hours postoperatively; the other group received perioperative remifentanyl as part of balanced anaesthesia regimen. All subjects were offered patient-controlled analgesia with fentanyl for postoperative pain. All surgeries were performed by the same surgical team, and a designated anaesthesia team was in charge of the respective groups. The two groups were similar with respect to age, sex, and weight as well as duration of anesthesia. Post-Anaesthesia Recovery There was no significant difference in the immediate postanaesthesia recovery between the ketorolac and remifentanyl groups. Mean time to eye opening was 3.7 minutes in the ketorolac group and 3.2 minutes in the remifentanyl group. Mean time to extubation and orientation was 4.2 minutes and 3.9 minutes, respectively. The incidence of postoperative nausea and vomiting was 4% in the ketorolac and 28% in the remifentanyl group. Incidence of pain and the need for antiemetic and analgesic medications in the postanaesthesia care unit, as well as time spent in the postanaesthesia care unit before discharge to the bariatric care unit were significantly shorter in the ketorolac group. In addition, continued administration of ketorolac led to improved patient satisfaction and more enthusiastic participation in respiratory physical therapy. Source: Author: Jill Stein Stomach Bypass Surgery Information |